Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $25.4000 (-0.39%) ($24.5000 - $25.7000) on Fri. Feb. 12, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.54% (three month average) | RSI | 62 | Latest Price | $25.4000(-0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.8% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) EWI(7%) PEJ(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.77% in a week (0% probabilities). TLT(-5%) VIXM(-4%) SLV(-3%) GLD(-3%) BND(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.77% (StdDev 5.54%) | Hourly BBV | 0 () | Intraday Trend | 3.7% | | | |
|
5 Day Moving Average | $25.32(0.32%) | 10 Day Moving Average | $25.84(-1.7%) | 20 Day Moving Average | $24.38(4.18%) | To recent high | -44.8% | To recent low | 26.4% | Market Cap | $500m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |